Wordt geladen...
Regulatory pathways for vaccines for developing countries.
Vaccines that are designed for use only in developing countries face regulatory hurdles that may restrict their use. There are two primary reasons for this: most regulatory authorities are set up to address regulation of products for use only within their jurisdictions and regulatory authorities in...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
World Health Organization
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585911/ https://ncbi.nlm.nih.gov/pubmed/15042235 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|